Author is bullish on Modular Medical (MODD), a development-stage insulin patch pump maker, citing its recent move above $0.50 and a 12-month forecast of ~$1.59.
MODD — LONG The author argues Modular Medical is a worthwhile investment because the stock just broke and held above $0.50, which they call massive given investor backing. The company is a development-stage medical device firm commercializing affordable insulin patch pumps to expand access to glycemic control beyond traditional pump users. The author cites a 12-month forecast of about $1.59 versus the current $0.50 as upside. No specific risk is stated beyond the development-stage nature implied.
Currently at .50 with a 12 month forecast at about 1.59, I really think $modd is worthwhile.
This Reddit post, published January 14, 2026, features u/Brilliant_Bag6343 discussing MODD. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Brilliant_Bag6343 · Tickers: MODD